HOWL
Price:
$1.545
Market Cap:
$68.85M
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company...[Read more]
Industry
Biotechnology
IPO Date
2021-04-30
Stock Exchange
NASDAQ
Ticker
HOWL
According to Werewolf Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Werewolf Therapeutics, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), HOWL's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Werewolf Therapeutics, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
The current Dividend Yield of Werewolf Therapeutics, Inc. (HOWL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Werewolf Therapeutics, Inc.’s Dividend Yield is less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%), less than Decibel Therapeutics, Inc. (0%), less than Celcuity Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Talaris Therapeutics, Inc. (0%), less than Adicet Bio, Inc. (0%), less than Cullinan Oncology, Inc. (0%), less than Vor Biopharma Inc. (0%), less than Third Harmonic Bio, Inc. (0%), less than Passage Bio, Inc. (0%), less than Acrivon Therapeutics, Inc. Common Stock (0%), less than Eliem Therapeutics, Inc. (0%), less than Molecular Partners AG (0%), less than MediciNova, Inc. (0%), less than Anebulo Pharmaceuticals, Inc. (0%), less than Champions Oncology, Inc. (0%), less than Cyteir Therapeutics, Inc. (0%),
Company | Dividend Yield | Market cap |
---|---|---|
0% | $435.59M | |
0% | $353.60M | |
0% | $75.28M | |
0% | $603.29M | |
0% | $2.82B | |
0% | $123.37M | |
0% | $461.15M | |
0% | $265.06M | |
0% | $116.44M | |
0% | $73.38M | |
0% | $706.59M | |
0% | $59.68M | |
0% | $478.07M | |
0% | $40.34M | |
0% | $190.55M | |
0% | $342.68M | |
0% | $200.54M | |
0% | $100.54M | |
0% | $35.27M | |
0% | $115.49M | |
0% | $108.71M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Werewolf Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Werewolf Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Werewolf Therapeutics, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Werewolf Therapeutics, Inc. (HOWL)?
What is the highest Dividend Yield for Werewolf Therapeutics, Inc. (HOWL)?
What is the 3-year average Dividend Yield for Werewolf Therapeutics, Inc. (HOWL)?
What is the 5-year average Dividend Yield for Werewolf Therapeutics, Inc. (HOWL)?
How does the current Dividend Yield for Werewolf Therapeutics, Inc. (HOWL) compare to its historical average?